Polymorphisms of serotonin transporter gene and psychological status in patients with multiple sclerosis

  • Shirin Farjadian Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Bahareh Fakhraei Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Niknam Iran Neurological Association, Tehran, Iran
  • Mahboubeh Nasiri Allergy Research Center, Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
  • Aslan Azad School of Pharmacy, International Branch, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mojtaba Farjam Noncommunicable Diseases Research Center, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Alireza Nikseresht Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Keywords: Multiple Sclerosis; Depression; Serotonin Reuptake Transporter Protein; C. Elegans; Genetic Variation

Abstract

Background: Multiple sclerosis (MS) is the most common neuroinflammatory disease in young adults. Anxiety and depression may predispose individuals to MS and flare-ups. Serotonin transmission is modified in some brain regions of patients with MS, and these changes may contribute to their psychiatric abnormalities. We studied the frequencies of common polymorphisms of the serotonin reuptake transporter (SERT) gene in patients with MS according to their psychological status. Methods: The 5-HTTLPR, rs25531, and STin2VNTR polymorphisms of the SERT gene were genotyped by polymerase chain reaction (PCR)-based methods in 100 patients with MS and 100 healthy controls. Results: There were no remarkable differences in SERT gene polymorphisms between patients with MS and healthy controls. Unlike the control group, 41% of the patients showed some degree of depression based on Beck Depression Inventory (BDI), but no association was observed between SERT gene polymorphisms after the patients were stratified by depression status. Conclusion: In addition to SERT gene polymorphisms, modulation of serotonin at the synapses may also be regulated by genetic variations in tryptophan hydroxylase type 2 and serotonin receptors. Further studies with functional brain imaging of the serotonergic system in patients with MS can provide information on the role of serotonin in this disease.
Published
2018-07-05
How to Cite
1.
Farjadian S, Fakhraei B, Niknam Z, Nasiri M, Azad A, Farjam M, Nikseresht A. Polymorphisms of serotonin transporter gene and psychological status in patients with multiple sclerosis. IJNL. 17(3).
Section
Original Article(s)